Mr. Bandali’s expertise in global operations, strategy development, driving innovation, M&A, and investment management has been developed over a 25-year career in the life sciences sector spanning contract clinical and research services, analytical instrumentation, lab services and venture capital.
He holds an Advanced Management Program Degree from Harvard Business School, a Master of Business Administration from McGill University, and a Bachelor of Science from the University of British Columbia. He is an innovative business leader who has built strategic and operating plans that have resulted in rapid growth and significant profitability enhancement. He has managed businesses and operations with a global footprint and has led teams of over 900 people.
Mr. Bandali previous experience includes serving as President, Early Phase Clinical Services and Translational Science, Syneos Health; President, Early Stage Development, as well as Chief Innovation Officer, inVentiv Health Clinical; Senior Vice President, Strategy and Business Development, AB Sciex and Molecular Devices (part of Danaher Corporation); Senior Vice President, Strategy, Legal and Corporate Development, MDS Analytical Technologies; and, Vice President and General Manager, Global Early Stage Development, MDS Pharma Services. He was also Venture Partner and Vice President at MDS Capital and has served on the boards of private and public companies.
Prior to assuming his role at Emerald, Allan was the inaugural Executive Director of the Cannabis Council of Canada, the National Trade Association for Health Canada approved Licenced Producers and Processors under Bill C-45. In this position, Allan played a key role in unifying multiple industry associations to create one singular national voice for the sector and then guided the industry successfully as Canada became the first G8 country to legalize adult-use cannabis.
As a result of this work, he was named as one of the ’20 power players setting down roots in the cannabis industry’ by the financial post.
Prior to entering the legal cannabis industry, Allan was a partner in a Toronto and Edmonton based government relation firm where he assisted clients to secure countless policy wins and over 300 million in direct provincial investments.